An experimental heart-failure drug that was shelved amid doubts about its usefulness appears to be a lifesaver in patients who carry a particular version of a heart-related gene, researchers are reporting today.
An experimental heart-failure drug that was shelved amid doubts about its usefulness appears to be a lifesaver in patients who carry a particular version of a heart-related gene, researchers are reporting today.
